Scientists have developed a holy grail insulin that responds to changing blood sugar levels in real-time, potentially revolutionizing type 1 diabetes treatment worldwide.
Glucose-responsive insulins (GRIs) mimic the body's natural response, becoming active only at specific blood sugar levels to prevent hypo- or hyperglycemia, offering a more sustainable treatment approach.
[
Collection
]
[
|
...
]